Us TOO in Seattle

Prostate Cancer Education, Support and Advocacy

Us TOO in Seattle Prostate Cancer Support Group meetings are open to men with prostate cancer, their loved ones, friends, and caregivers. Our goal is to provide comprehensive information on prostate cancer, its diagnoses, treatments, side effects, current research and other aspects that may be used to help us make informed decisions about the disease. Us TOO in Seattle monthly meetings offer peer-to-peer interaction and support, plus unbiased information from experts in areas related to prostate cancer including surgery, radiation, medication, psychology, healthy lifestyles, and more.

Spouses, partners, other family members and caregivers are welcome.

 Each Us TOO in Seattle meeting starts at 6pm with a facilitated discussion between participants followed by an educational presentation at 7pm by a healthcare provider or other speaker.  Meetings end promptly at 8:00.

Next Meeting  

Wednesday, March 15, 2023, 6 -8 pm

Online only 

Guest speaker: Dr. Heather Cheng

Subject: Prostate Cancer Genetics and Genomics

Dr. Heather Cheng is an Associate Professor in the Division of Medical Oncology, Department of Medicine, University of Washington. Dr. Cheng focuses on improving the care of patients with prostate and bladder cancers. An expert in prostate cancer genetics, she is studying ways to use genetics to guide the care of prostate cancer patients and their family members who may also be at high risk for the disease. Dr. Cheng leads clinical trials of a variety of new treatments for prostate cancer. She is also developing new tests that could help guide doctors’ choice of treatment for each patient and new blood tests to detect and monitor the progression of prostate cancer.

 Join us via Zoom. Contact Marty Chakoian marty@chakoian.com for the link.  

 

Future Meetings: 

Wednesday, March 22, 2023: 6:00 p.m.   Prostate Cancer Discussion Group, in person only at the Greenwood Senior Center, 525 N 85th St., Seattle

 

Dr. Michael Schweizer is an oncologist who specializes in treating patients with bladder, prostate and testicular cancers. His research focuses on developing new drugs and therapies to treat these cancers and to help speed advances from the lab into the clinic. He leads a number of innovative translational clinical trials, including studies evaluating high-dose testosterone as a therapeutic option for men with advanced prostate cancer.
Dr. Michael Schweizer is an oncologist who specializes in treating patients with bladder, prostate and testicular cancers. His research focuses on developing new drugs and therapies to treat these cancers and to help speed advances from the lab into the clinic. He leads a number of innovative translational clinical trials, including studies evaluating high-dose testosterone as a therapeutic option for men with advanced prostate cancer.
Dr. Michael Schweizer is an oncologist who specializes in treating patients with bladder, prostate and testicular cancers. His research focuses on developing new drugs and therapies to treat these cancers and to help speed advances from the lab into the clinic. He leads a number of innovative translational clinical trials, including studies evaluating high-dose testosterone as a therapeutic option for men with advanced prostate cancer.

 

 

Upcoming Events

Wednesday, Apr 19 at 6:00 PM - 8:00 PM
Wednesday, Apr 26 at 6:00 PM - 8:00 PM
Wednesday, Apr 26 at 6:00 PM - 8:00 PM
Wednesday, May 17 at 6:00 PM - 8:00 PM